Understanding CAN/CSA Z23328-2-03 (R2018): Breathing System Filters for Anaesthetic and Respiratory Use – Non-Filtration Aspects

A comprehensive guide to the Canadian standard for mechanical, flow, and safety requirements of breathing system filters in anaesthesia and respiratory care

Scope and Purpose

CAN/CSA Z23328-2-03 (R2018) is the Canadian adoption of the international standard ISO 23328-2:2002, titled Breathing system filters for anaesthetic and respiratory use — Part 2: Non-filtration aspects. This standard specifies requirements and test methods for the mechanical, fluid dynamic, and other non-filtration performance characteristics of breathing system filters (BSFs) intended for use in anaesthetic breathing systems and respiratory circuits.

While Part 1 (CAN/CSA Z23328-1-03) addresses filtration performance, Part 2 focuses on aspects such as:

  • Biocompatibility and materials safety
  • Mechanical integrity (e.g., burst pressure, leak testing)
  • Airflow resistance (pressure drop)
  • Dead space and internal volume
  • Connections and port compatibility
  • Labelling and packaging requirements

First published in 2003 and reaffirmed in 2018 without technical change, the standard remains current for Canadian medical device manufacturers, healthcare facilities, and regulatory bodies. It applies to both single-use and reusable filters intended for placement in the breathing system between the patient and the anaesthesia machine or ventilator.

Note: CAN/CSA Z23328-2-03 (R2018) is identical to ISO 23328-2:2002. It does not supersede any requirements in the Canadian Medical Devices Regulations (SOR/98-282) but provides supporting evidence for safety and performance.

Technical Requirements

Materials and Biocompatibility

The standard mandates that all materials in contact with the patient or breathing gases shall be evaluated for biocompatibility according to ISO 10993 series (or equivalent). Materials must not release particles, fibres, or volatile compounds at levels that could pose a risk to patients or healthcare personnel. The filter medium itself must be compatible with common anaesthetic agents and disinfectants (if reusable).

Mechanical Integrity

Filters must withstand a static internal pressure of at least 100 % above the maximum working pressure (typically 60 kPa) without rupture or permanent leakage. A leak test at 3 kPa ensures that the filter housing and seals maintain integrity under negative pressure scenarios. For reusable filters, the standard requires verification after the specified number of reprocessing cycles.

Flow Resistance (Pressure Drop)

Pressure drop at a specified continuous flow rate (typically 30 L/min for paediatric filters, 60 L/min for adult) must be within manufacturer-declared limits. The test method uses a calibrated flow source and differential pressure transducer with an accuracy of ±2 %. Table 1 summarises typical classification thresholds defined in the standard.

TypeFlow rate (L/min)Max. initial pressure drop (Pa)Max. pressure drop after clinical use
Paediatric303001.5 × initial
Adult604001.5 × initial
High-flow adult1006001.5 × initial

Table 1: Pressure drop thresholds (informative based on typical manufacturer claims)

Dead Space and Internal Volume

The internal volume of the filter (including both ports) must be declared by the manufacturer. For paediatric filters, dead space should not exceed 10 mL; for adult filters, it must be less than 50 mL. The standard provides volumetric measurement methods using water displacement or gas dilution techniques.

Connections and Port Compatibility

All patient and machine ports must conform to ISO 5356-1 (22 mm conical connectors) or ISO 5356-2 (luer locks for paediatric applications). Additional requirements include secure engagement, absence of sharp edges, and tamper-evident features for single-use products.

Labelling and Instructions

The standard requires that each filter unit and its packaging display:

  • Intended patient population (adult, paediatric, neonatal)
  • Maximum working pressure and flow rate range
  • Single-use or reusable status with reprocessing instructions where applicable
  • Batch/lot number and expiry date
  • Symbol for medical device per ISO 15223

Implementation Highlights

Manufacturers seeking compliance with CAN/CSA Z23328-2-03 (R2018) should incorporate the following into their design and quality processes:

  • Risk management per ISO 14971: Non-filtration aspects (e.g., occlusion by humidity, chemical degradation) must be addressed in the risk analysis.
  • Design verification testing: Formal tests for pressure drop, leak, burst, and dimensional checks shall be performed on representative production samples.
  • Stability programme: For single-use filters, accelerated aging and real-time aging tests validate the shelf life; for reusable filters, the number of reprocessing cycles must be validated.
  • Clinical evaluation: While Part 2 focuses on bench tests, the manufacturer must provide clinical evidence that the filter does not significantly affect ventilation or gas exchange.
Tip: When designing a reusable filter, ensure that the pressure drop after the maximum number of reprocessing cycles does not exceed 50 % of the initial value. This can be a critical limiting factor for repeated steam sterilisation or chemical disinfection.

Healthcare providers should also consider the standard when selecting filters for specific patient groups. For example, a filter with dead space greater than 30 mL should not be used in neonatal circuits without careful assessment of rebreathing potential.

Important: CAN/CSA Z23328-2-03 (R2018) does not address viral or bacterial filtration efficiency. That is covered exclusively in Part 1. A compliant filter must be assessed against both parts to cover all safety aspects.

Compliance and Regulatory Notes

While this standard is voluntary in Canada, it is referenced by Health Canada as a recognised consensus standard for demonstrating safety and effectiveness under the Medical Devices Regulations. Manufacturers of Class II / III devices (breathing system filters are typically Class II under Rule 7) may apply the standard to support a Medical Device Licence (MDL) application.

Key points for compliance:

  • A declaration of conformity to CAN/CSA Z23328-2-03 (R2018) must be backed by a technical file containing test reports, design documentation, and a risk management file.
  • The standard requires periodic re-testing if the design is modified or if production materials change.
  • For imports, ISO 23328-2:2002 is also widely recognised, but Canadian labelling (bilingual English/French) may be required in addition to the standard’s requirements.
Compliance benefit: Using a filter certified to CAN/CSA Z23328-2-03 (R2018) simplifies conformity assessment and provides strong defence in liability cases by demonstrating adherence to a national standard of care.

It is important to note that the 2018 reaffirmation did not update the technical content; however, manufacturers should still consider current Canadian guidance documents and any relevant amendments to the Medical Devices Regulations that have come into force since 2018.

Caution: Using a filter that does not meet the dead space or pressure drop requirements of CAN/CSA Z23328-2-03 (R2018) may lead to patient hypoventilation, increased work of breathing, or paradoxical carbon dioxide rebreathing, especially in paediatric and neonatal patients.

Overall, adherence to this standard, together with Part 1 and applicable international standards (ISO 5356, ISO 80601-2-13 for anaesthesia ventilators), forms a solid foundation for the safe and effective use of breathing system filters in Canadian healthcare settings.

Frequently Asked Questions

Q: What is the difference between CAN/CSA Z23328-2-03 (R2018) and ISO 23328-2:2002?
A: CAN/CSA Z23328-2-03 (R2018) is the identical adoption of ISO 23328-2:2002 with no deviations. The only difference is the designation number and the inclusion of Canadian bilingual labelling references in the national foreword. The technical requirements, test methods, and normative references are the same.
Q: Can a filter comply with Part 2 without also complying with Part 1?
A: Yes, but for a complete safety and performance assessment, both parts should be used together. A filter that meets only Part 2 may still fail to provide adequate filtration efficiency, which is critical for protecting the patient and equipment from microbial contamination.
Q: Is the 2018 reaffirmation still current, or has it been superseded?
A: As of 2026, CAN/CSA Z23328-2-03 (R2018) remains current. No newer version has been published. However, users should monitor CSA Group’s updates and Health Canada’s list of recognised standards for any changes or replacement standards.
Q: What are the most common non-compliance issues found with breathing system filters?
A: The most frequent issues include: (1) excessive pressure drop after packaging compression, (2) inaccurate dead space labelling, (3) failure of the housing leak test after assembly, and (4) inadequate resistance to disconnect forces on the connectors. Ensuring thorough design verification against the test methods in CAN/CSA Z23328-2-03 (R2018) can prevent these problems.


© 2026 Standards Publications. This article is for informational purposes and does not replace the full text of CAN/CSA Z23328-2-03 (R2018). Always refer to the official standard for precise requirements.

📥 Standard Documents Download

🔒
Please wait 10 seconds, the download links will appear after the ad loads

Leave a Reply

Your email address will not be published. Required fields are marked *